Friday 4th April 2025 13:00 - 14:00 (BST)
Generics, branded generics, and biosimilars are the lifeblood of the NHS, accounting for over 80% of medicines by volume across major therapy areas. These medicines not only provide high-quality, life-changing treatments to patients but also deliver unmatched value to the NHS by enabling access and cost savings.
As we enter a new financial year, this 60-minute masterclass offered Life Sciences professionals a critical update on the trends, challenges, and opportunities shaping the generics and biosimilars sectors in 2025.
Led by our esteemed panel of industry leaders, you’ll explore how these medicines address NHS priorities, the evolving policy landscape, and their growing role in patient care.
4th Apr 2025 13:00 – 14:00 (BST)
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now